Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary. (Record no. 29129599)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01179 a2200301 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518012421.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202004s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1099-1557 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/pds.4697 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Girman, Cynthia J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200427 |
| 245 00 - TITLE STATEMENT | |
| Title | Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Pharmacoepidemiology and drug safety |
| Date of publication, distribution, etc. | 04 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 439-442 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Data Accuracy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Approval |
| General subdivision | legislation & jurisprudence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pragmatic Clinical Trials as Topic |
| General subdivision | legislation & jurisprudence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Research Design |
| General subdivision | standards |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States Food and Drug Administration |
| General subdivision | legislation & jurisprudence |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ritchey, Mary E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhou, Wei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dreyer, Nancy A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Pharmacoepidemiology and drug safety |
| Related parts | vol. 28 |
| -- | no. 4 |
| -- | p. 439-442 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/pds.4697">https://doi.org/10.1002/pds.4697</a> |
| Public note | Available from publisher's website |
No items available.